LumiraDx Investor Presentation Deck

100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Innovation and Growth in High Sensitivity Respiratory Antigen Testing Q1 2022 Respiratory Revenue Distribution Top 3 Countries - Italy, UK, Japan lumiraDx™ Q2 2022 Q3 2022 Q4 2022 ■COVID AgCOVID Ag Pool COVID Ag UltraCOVID Ag Ultra Pool COVID & Flu Copyright © 2023 LumiraDx Ltd. All Rights Reserved, Worldwide. Launch timelines ● ● ● COVID Ag CE Mark in Aug 2020 COVID Ag PMDA (Japan) in Jan 2021 COVID Ag Pool CE Mark in Jun 2021 COVID & Flu CE Mark in Dec 2021 COVID & Flu PMDA (Japan) in Mar 2022 COVID Ag Ultra and COVID Ag Ultra Pool CE Mark in May 2022

View entire presentation